Page 1,916«..1020..1,9151,9161,9171,918..1,9301,940..»

Ask A Doctor: Raise brain injury awareness – Herald Times Reporter

Posted: Published on March 7th, 2017

Dr. Paul Baek, For USA TODAY NETWORK-Wisconsin Published 1:32 p.m. CT March 6, 2017 | Updated 17 hours ago Dr. Paul Baek(Photo: Provided) Question: How big a deal is Brain Injury Awareness Month? Answer: Its a big deal, because were not talking about it frequently enough. Brain injury is often referred to as a silent epidemic because few people know about it, despite the eye-opening number of people injured each year. RELATED:Ask A Doctor: Facts about multiple sclerosis SUBSCRIBE:Follow us today on YouTube More than 3.5 million people experience a brain injury each year, according to the Brain Injury Association of America. An estimated 12 million Americans live with the impact of such an injury. A brain injury can occur anytime our head is subjected to a strong bump, blow, jolt or penetrating injury that interrupts the normal function of the brain. Some brain injuries are traumatic, such as a head injury sustained during a car crash. Some are the result ofnon-traumatic causes like drowning, stroke or infection. Others are less severe, but may still cause disturbances in normal brain function, as experienced during a concussion. Creating awareness of brain injuries and how to prevent them is critical. Given that … Continue reading

Posted in Brain Injury Treatment | Comments Off on Ask A Doctor: Raise brain injury awareness – Herald Times Reporter

Poulsen Studies Neuroprotective Agent for Traumatic Brain Injury … – UB School of Medicine and Biomedical Sciences News

Posted: Published on March 7th, 2017

David Poulsen, PhD, professor of translational neuroscience in the Department of Neurosurgery, has received $966,000 in private funding to further study a novel neuroprotective agent for moderate-to-severe traumatic brain injury (TBI). Poulsens previous work on developing therapies to treat injuries to the central nervous system strongly suggest that phenoxybenzamine is highly neuroprotective when given within eight hours after a severe TBI. Phenoxybenzamine is an FDA-approved treatment for humans and animals to reduce hypertension and excessive sweating associated with adrenal tumors, but Poulsen says it may also may exert a neuroprotective effect by reducing neuroinflammation after TBI. Poulsens new study titled Preclinical Therapeutic Window Study of Phenoxybenzamine in Moderate-Severely Injured TBI Rats encompasses several goals: This will define how long after injury phenoxybenzamine can be given and still produce a beneficial effect, Poulsen says. This will provide us with a comprehensive picture of the neuropathology that occurs in the brain following TBI and help us to understand what molecular mechanisms are involved in phenoxybenzamine-mediated neuroprotection, Poulsen says. TBI is a national health concern that affects more than 1.7 million individuals each year in the United States. Of further concern is the lack of effective treatments to reduce the primary or secondary … Continue reading

Posted in Brain Injury Treatment | Comments Off on Poulsen Studies Neuroprotective Agent for Traumatic Brain Injury … – UB School of Medicine and Biomedical Sciences News

DARPA’s Brain Chip Implants Could Be the Next Big Mental Health BreakthroughOr a Total Disaster – Gizmodo

Posted: Published on March 7th, 2017

How did a Massachusetts woman end up with two electrodes implanted into her brain? Why is the Defense Advanced Research Projects Agency developing a controversial, cutting-edge brain chip technology that could one day treat everything from major depressive disorder to hand cramps? How did we get to deep brain stimulation and where do we go from here? In 1848, a rail foreman named Phineas Gage was clearing a railroad bend in Vermont when a blast hole exploded, sending the tamping iron he had been using to pack explosives through his left cheek, his brains left frontal lobe and finally out the top of his skull before landing 25 yards away, stuck upright in the dirt. Despite his pulverized brain mass, Gage went on to make a full recovery, with the exception of a blinded left eye. It was, by all accounts, miraculous. But while Gage could walk and talk, those who knew him found that after the accident he seemed, well, different. A local physician who treated him the day of the accident observed that the equilibrium ... between his intellectual faculties and his animal propensities seems to have been destroyed. His friends put it more simply: Gage, they said, … Continue reading

Posted in Brain Injury Treatment | Comments Off on DARPA’s Brain Chip Implants Could Be the Next Big Mental Health BreakthroughOr a Total Disaster – Gizmodo

Local resident tries new treatment to fight MS – Martinsburg Journal

Posted: Published on March 7th, 2017

Submitted photo The Hess family enjoys time together around Christmas 2016 as Kelly Hess, right, goes through a new drug treatment plan for multiple sclerosis. MARTINSBURG Kelly Hess is a hardworking family man. He lives with his wife and two children and goes to work every day. In 2013, however, everything changed. One day I woke up, I think it was a Saturday, and had a tingling in my feet and then by Monday I was numb from the chest down, Hess said. He went to urgent care, and they sent him to the Winchester Emergency Room. I was there for three days, Hess said. It was there that Hess was informed that he has multiple sclerosis or MS. Hess said he had only heard of MS and wasnt even sure what it was. I had no idea, no idea. My education with that started when I got diagnosed. They brought me pamphlets and paperwork and stuff like that told me what I had, and that was the first time that I really had been exposed to anything other than the name of it, Hess said. Hess said limitations accompany the diagnosis. I have balance issues its harder to walk … Continue reading

Posted in MS Treatment | Comments Off on Local resident tries new treatment to fight MS – Martinsburg Journal

Mouse embryo arises from stem cells – CNN.com

Posted: Published on March 7th, 2017

The artificial structure shows promise as a tool for medical research, though it cannot develop into an actual baby. After an egg is fertilized by a sperm, it begins to divide multiple times. This process generates a small, free-floating ball of stem cells: a blastocyst. Within a mammalian blastocyst, the cells that will become the body of the embryo (embryonic stem cells) begin to cluster at one end. Two other types of cells, the extra-embryonic trophoblast stem cells and the endoderm stem cells, begin to form patterns that will eventually become a placenta and a yolk sac, respectively. To develop further, the blastocyst has to implant in the womb, where it transforms into a more complex architecture. However, implantation hides the embryo from view -- and from experimentation. In the study, Zernicka-Goetz wanted to replicate developing embryonic events using stem cells. Other scientists who have attempted the same thing have used only embryonic stem cells, but these experiments, though they have yielded embryoid bodies, have not been entirely successful. The artificial bodies never follow the same chain of events found in nature, and they lack the structure of a natural embryo. Zernicka-Goetz, a professor in Cambridge's Department of Physiology, Development … Continue reading

Posted in Stem Cell Research | Comments Off on Mouse embryo arises from stem cells – CNN.com

Cynata Therapeutics talks stem cell research at Proactive’s CEO Sessions – Proactive Investors Australia

Posted: Published on March 7th, 2017

Find out more from Dr Ross Macdonald at Proactive's CEO Sessions. Cynata Therapeutics (ASX:CYP) is a stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus. The technology addresses a critical shortcoming in existing methods of production of mesenchymal stem cells (MSCs) for therapeutic use. Cynata is now in a transition to a clinical stage company. Earlier this year Cynata announced a breakthrough strategic partnership agreement with Fujifilm which included the Japanese company investing in Cynata to become the largest shareholder in the company. Find out more from Dr Ross Macdonald at Proactive's CEO Sessions. Click on city below to register by email - Sydney: Tuesday 14th March. - Melbourne: Wednesday 15th March. - Email Pauline here. - Call office on (02) 9280 0700. Presenter list - Legend Mining (ASX:LEG): Mark Wilson. - Cynata Therapeutics (ASX:CYP): Dr Ross Macdonald. - White Cliff Minerals (ASX:WCN): Todd Hibberd. - Bluechiip (ASX:BCT): Andrew McLellan. Register here to be notified of future CYP Company articles Read more from the original source: Cynata Therapeutics talks stem cell research at Proactive's CEO Sessions - Proactive Investors Australia … Continue reading

Posted in Stem Cell Research | Comments Off on Cynata Therapeutics talks stem cell research at Proactive’s CEO Sessions – Proactive Investors Australia

Lloyd-Jones Honored for Work in Preventive Cardiology – Northwestern University NewsCenter

Posted: Published on March 6th, 2017

Donald Lloyd-Jones, MD, senior associate dean for Clinical and Translational Research and chair of Preventive Medicine, will receive the receive The American Society for Preventive Cardiologys 2017 Joseph Stokes, III, MD Award. Donald Lloyd-Jones, MD, ScM, senior associate dean for Clinical and Translational Research and chair of Preventive Medicine, has been selected to receive the 2017 Joseph Stokes, III, MD Award from the American Society for Preventive Cardiology (ASPC) for his achievements in preventive cardiology. Presented annually, the award commemorates Joseph Stokes III, MD, a physician who contributed to the fields of cardiology and epidemiology as well as to the ASPC. I am truly honored to receive the Joseph Stokes, III, MD Award, and it is profoundly humbling to join such a prestigious list of prior awardees, said Lloyd-Jones. The Stokes Award is especially meaningful to me as it has previously been awarded to a number of my mentors, including Bill Kannel in 2011, with whom I worked at Framingham, and Jerry Stamler in 2012, Phil Greenland in 2002, and Darwin Labarthe in 2006, who are all current faculty here in our Department of Preventive Medicine at Feinberg. Lloyd-Jones will be presented with the award during the Epi-Lifestyle Meeting on … Continue reading

Posted in Cardiology | Comments Off on Lloyd-Jones Honored for Work in Preventive Cardiology – Northwestern University NewsCenter

IQ4I Research & Consultancy Published a New Report on Interventional Cardiology Global Market Forecast to 2023 – Satellite PR News (press…

Posted: Published on March 6th, 2017

IQ4I Research & Consultancy Published a New Report on Interventional Cardiology Global Market Forecast to 2023 Interventional cardiology deals with catheter based less invasive techniques for treatment of various cardiovascular diseases, the changing demography, increasing lifestyle disease are increasing the demand for less invasive, cost effective procedures. Boston, MA, March 06, 2017 (PR.com) Interventional cardiology deals with the catheter based techniques for the treatment of cardiovascular diseases such as coronary and peripheral artery diseases, valvular and congenital heart diseases and structural heart diseases. As estimated by IQ4I Research the interventional cardiology global is expected to grow at high single digit CAGR to reach $46,124.1 million by 2023. The Interventional cardiology global market by products is segmented into catheters, stents, valves, interventional diagnostic devices, transcatheter heart pump and others. Interventional cardiology market by applications includes diagnostic catheterization, coronary interventions, peripheral interventions and structural heart. Among the products stents held the highest share due to wide acceptance of stent procedures, a minimal invasive surgery with less risk of complications than open surgery. Transcatheter heart pump segment is project to grow at a very high double digit CAGR. Abiomed, U.S. based medical device company has developed worlds smallest catheter based heart pump that … Continue reading

Posted in Cardiology | Comments Off on IQ4I Research & Consultancy Published a New Report on Interventional Cardiology Global Market Forecast to 2023 – Satellite PR News (press…

Biotechnology group names Thune its legislator of the year – Watertown Public Opinion

Posted: Published on March 6th, 2017

SIOUX FALLS Sen. John Thune (RS.D.) has been named Legislator of the Year from the international Biotechnology Innovation Organizations Industrial & Environmental Health Section. The award recognizes Senator Thunes support of the biotechnology industry and steadfast commitment to growing South Dakotas and the nations bio-based economy. Thunes award was presented by Doug Berven, a member of BIOs governing board and vice president of corporate affairs at Sioux Falls-based POET, and Brent Erickson, executive vice president of BIOs Industrial & Environmental Section. Sen. John Thune has been a strong and constant champion of policies that support industrial biotechnology companies in creating jobs, revitalizing manufacturing, improving U.S. energy security and building a bio-based economy, Erickson said. Senator Thune was first elected to the Senate in 2004, when the first Renewable Fuel Standard was under development. He helped expand the program in 2007 and has been a determined advocate in encouraging the Environmental Protection Agency to get the program on track for future growth. Thune also was recognized helping renew tax credits for second-generation biofuels and for co-sponsoring legislation to ensure mandatory funding for energy programs in the Agriculture Act of 2014. Through his efforts, Congress has incorporated innovative programs in the Farm … Continue reading

Posted in Biotechnology | Comments Off on Biotechnology group names Thune its legislator of the year – Watertown Public Opinion

Study Free Profits From iShares Nasdaq Biotechnology Index (ETF) (IBB) Stock – Investorplace.com

Posted: Published on March 6th, 2017

The biotech industry had a rough 12 months. First the beatings came from presidential hopeful Hillary Clinton as she vowed to crush their pricing models. Now President Donald Trump is following up with similar promises. For a long while, tickers like the iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) were toxic to investors. The thesis was that healthcare and biotech companies were untouchable with the political cloud looming above them. Recently, and in spite of the fact that that nothing has changed from the political standpoint, the worrisome headlines became stale and lost their zing. Thats what usually happens. Traders initially over-react to the headline and then after a while, return to trading the fundamentals. The companies in the IBB have legitimate, viable businesses. This is a classic case of a bad apples who spoil the bunch. Technically the IBB stock price is in a breakout that I rode higher on Feb. 11 with debit call spreads. The important price action came when the IBB reclaimed the $280 per share pivotal zone. From here at the $300 per share level, it can once again provide a base from which to mount another leg higher. This area is an important long term … Continue reading

Posted in Biotechnology | Comments Off on Study Free Profits From iShares Nasdaq Biotechnology Index (ETF) (IBB) Stock – Investorplace.com

Page 1,916«..1020..1,9151,9161,9171,918..1,9301,940..»